Education
About Us
Working with TipRanks
Follow Us
Jubilant Pharmova Limited (IN:JUBLPHARMA)
:JUBLPHARMA
RESEARCH TOOLSreports
Total Valuation
Jubilant Pharmova Limited has a market cap or net worth of ₹165.92B. The enterprise value is ₹203.20B.
Market Cap₹165.92B
Enterprise Value₹203.20B
Share Statistics
Jubilant Pharmova Limited has 159,281,140 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding159,281,140
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Jubilant Pharmova Limited’s return on equity (ROE) is 0.13 and return on invested capital (ROIC) is 20.67%.
Return on Equity (ROE)0.13
Return on Assets (ROA)0.07
Return on Invested Capital (ROIC)20.67%
Return on Capital Employed (ROCE)0.25
Revenue Per Employee13.40M
Profits Per Employee1.55M
Employee Count5,399
Asset Turnover0.57
Inventory Turnover2.05
Valuation Ratios
The current PE Ratio of Jubilant Pharmova Limited is 35.8. Jubilant Pharmova Limited’s PEG ratio is ―.
PE Ratio35.8
PS Ratio―
PB Ratio―
Price to Fair Value2.33
Price to FCF―
Price to Operating Cash Flow0.00
PEG Ratio―
Income Statement
In the last 12 months, Jubilant Pharmova Limited had revenue of 72.34B and earned 8.39B in profits. Earnings per share was 52.99.
Revenue72.34B
Gross Profit49.17B
Operating Income26.50B
Pretax Income9.81B
Net Income8.39B
EBITDA11.74B
Earnings Per Share (EPS)52.99
Cash Flow
In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.
Operating Cash Flow0.00
Free Cash Flow0.00
Free Cash Flow per Share0.00
Dividends & Yields
Jubilant Pharmova Limited pays an annual dividend of ₹5, resulting in a dividend yield of 0.48%
Dividend Per Share₹5
Dividend Yield0.48%
Payout Ratio16.31%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.21
52-Week Price Change13.41%
50-Day Moving Average1.14K
200-Day Moving Average1.04K
Relative Strength Index (RSI)33.57
Average Volume (3m)13.97K
Important Dates
Jubilant Pharmova Limited upcoming earnings date is Oct 17, 2025, TBA (Confirmed).
Last Earnings DateJul 29, 2025
Next Earnings DateOct 17, 2025
Ex-Dividend DateJul 25, 2025
Financial Position
Jubilant Pharmova Limited as a current ratio of 1.65, with Debt / Equity ratio of 43.66%
Current Ratio1.65
Quick Ratio1.13
Debt to Market Cap0.17
Net Debt to EBITDA1.40
Interest Coverage Ratio11.03
Taxes
In the past 12 months, Jubilant Pharmova Limited has paid 1.44B in taxes.
Income Tax1.44B
Effective Tax Rate0.15
Enterprise Valuation
Jubilant Pharmova Limited EV to EBITDA ratio is 13.81, with an EV/FCF ratio of -372.57.
EV to Sales2.24
EV to EBITDA13.81
EV to Free Cash Flow-372.57
EV to Operating Cash Flow15.12
Balance Sheet
Jubilant Pharmova Limited has ₹10.89B in cash and marketable securities with ₹27.31B in debt, giving a net cash position of ₹16.42B billion.
Cash & Marketable Securities₹10.89B
Total Debt₹27.31B
Net Cash₹16.42B
Net Cash Per Share₹103.10
Tangible Book Value Per Share₹163.76
Margins
Gross margin is 58.92%, with operating margin of 36.62%, and net profit margin of 11.60%.
Gross Margin58.92%
Operating Margin36.62%
Pretax Margin13.55%
Net Profit Margin11.60%
EBITDA Margin16.22%
EBIT Margin11.13%
Analyst Forecast
The average price target for Jubilant Pharmova Limited is ₹1,385.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target₹1,385.00
Price Target Upside33.26% Upside
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast8.12%
EPS Growth Forecast-16.64%